COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 1256: Articles 12551-12560  | Next

A Genotype-to-Phenotype Modeling Framework to Predict Human Pathogenicity of Novel Coronaviruses
Davis, P., Russell, J. A.
10.1101/2021.09.18.460926 — Posted: 2021-09-20
COVID-19 Vaccination and Healthcare Demand
Betti, M., Hassan Abouleish, A., Spofford, V., Peddigrew, C., Diener, A., Heffernan, J. M.
10.1101/2021.09.15.21263628 — Posted: 2021-09-20
Analysis of the upper respiratory tract microbiota in mild and severe COVID-19 patients
Babenko, V. V., Bakhtyev, R. R., Baklaushev, V. P., Balykova, L. A., Bashkirov, P. V., Bespyatykh, J. A., Blagonravova, A. S., Boldyreva, D. I., Fedorov, D. E., Gafurov, I. R., Gaifullina, R. F., Galeeva, J. S., Galova, E. A., Gospodaryk, A. V., Ilina, E. N., Ivanov, K. P., Kharlampieva, D. D., Khromova, P. A., Klimina, K. M., Kolontarev, K. B., Kolyshkina, N. A., Koritsky, A. V., Kuropatkin, V. A., Lazarev, V. N., Manolov, A. I., Manuvera, V. A., Matyushkina, D. S., Morozov, M. D., Moskaleva, E. V., Musarova, V. A., Ogarkov, O. B., Orlova, E. A., Pavlenko, A. V., Petrova, A. G., Pozhenko, N. S., Pushkar, D. Y., Rumyantsev, A. G., Rumyantsev, S. A., Rumyantsev, V. A., Rychkova, L. V., Samoilov, A. S., Shirokova, I. Y., Sinkov, V. V., Solovieva, S. V., Starikova, E. V., Tikhonova, P. O., Trifonova, G. S., Troitsky, A. V., Tulichev, A. A., Udalov, Y. D., Varizhuk, A. M., Vasiliev, A. O., Veselovsky, V. A., Volnukhin, A. I., Yusubalieva, G. M., Govorun, V. M.
10.1101/2021.09.20.461025 — Posted: 2021-09-20
Correlates of COVID-19 vaccine acceptance, hesitancy and refusal among employees of a safety net California county health system with an early and aggressive vaccination program: Results from a cross-sectional survey
Gatto, N. M., Lee, J. E., Massai, D., Zamarripa, S., Sasaninia, B., Khurana, D., Michaels, K., Freund, D., Nightingale, J., Firek, A.
10.1101/2021.09.14.21263588 — Posted: 2021-09-20
Evolution of COVID-19 mortality over time: results from the Swiss hospital surveillance system (CH-SUR)
Roelens, M., Martin, A., Friker, B., Maximiano Sousa, F., Thiabaud, A., Vidondo, B., Buchter, V., Gardiol, C., Vonlanthen, J., Balmelli, C., Battegay, M., Berger, C., Buettcher, M., Cusini, A., Flury, D., Heininger, U., Niederer-Loher, A., Riedel, T., Schreiber, P. W., Sommerstein, R., Troillet, N., Tschudin-Sutter, S., Vetter, P., Bernhard-Stirnemann, S., Corti, N., Gaudenz, R., Marschall, J., Nussbaumer-Ochsner, Y., Senn, L., Vuichard-Gysin, D., Zimmermann, P., Zucol, F., Iten, A., Keiser, O.
10.1101/2021.09.14.21263153 — Posted: 2021-09-20
Spatiotemporal analyses illuminate the competitive advantage of a SARS-CoV-2 variant of concern over a variant of interest
Russell, A., O'Connor, C., Lasek-Nesselquist, E., Plitnick, J., Kelly, J. P., Lamson, D. M., St George, K.
10.1101/2021.09.14.21262977 — Posted: 2021-09-20
Quantitative measurement of infectious virus in SARS-CoV-2 Alpha, Delta and Epsilon variants reveals higher infectivity (viral titer:RNA ratio) in clinical samples containing the Delta and Epsilon variants.
Despres, H. W., Mills, M. G., Shirley, D. J., Schmidt, M. M., Huang, M.-L., Jerome, K. R., Greninger, A. L., Bruce, E. A.
10.1101/2021.09.07.21263229 — Posted: 2021-09-20 Discussion: Offsite
Self-reported and physiological reactions to the third BNT162b2 mRNA COVID-19 (booster) vaccine dose
Mofaz, M., Yechezkel, M., Guan, G., L. Brandeau, M., Patalon, T., Gazit, S., Yamin, D., Shmueli, E.
10.1101/2021.09.15.21263633 — Posted: 2021-09-20
Detection of SARS-CoV-2 in the community by nucleic acid amplification testing of saliva
Fronza, F., Groff, N., Martinelli, A., Passerini, B. Z., Rensi, N., Cortelletti, I., Vivori, N., Adami, V., Helander, A., Bridi, S., Pancher, M., Greco, V., Garritano, S. I., Piffer, E., Stefani, L., De Sanctis, V., Bertorelli, R., Pancheri, S., Collini, L., Quattrone, A., Capobianchi, M. R., Icardi, G., Poli, G., Caciagli, P., Ferro, A., Pizzato, M.
10.1101/2021.09.15.21263644 — Posted: 2021-09-20
Distributed Counterfactual Modeling Approach for Investigating Hospital-Associated Racial Disparities in COVID-19 Mortality
Edmondson, M. J., Luo, C., Islam, N., Asch, D., Bian, J. J., Chen, Y.
10.1101/2021.09.14.21263596 — Posted: 2021-09-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).